Post‐Hematopoietic Stem Cell Transplantation Eczematous Dermatitis Spectrum Successfully Treated With Dupilumab: A Case Series and Review of the Literature
Dupilumab appears to be effective and safe for eczematous lesions occurring after HSCT, regardless of whether the histopathological characteristics align with eczema or GvHD. This supports a shared spectrum between eczematous dermatitis and GvHD, and the use of a neutral diagnostic term. Further research is needed to clarify its pathogenesis.
Authors
- Belén Rodríguez Sánchez (ORCID: https://orcid.org/0009-0007-0694-4757)
- Antonio del Alcalá‐Ramírez del Puerto (ORCID: https://orcid.org/0009-0004-0640-2200)
- Cristina Beléndez‐Bieler
- Eulàlia Baselga (ORCID: https://orcid.org/0000-0003-1086-8439)
- Verónica Parra‐Blanco
- Eduardo J. Bardón-Cancho (ORCID: https://orcid.org/0000-0002-7818-3463)
- M.T. Monserrat-García (ORCID: https://orcid.org/0000-0001-9211-9161)
- Minia Campos‐Domínguez (ORCID: https://orcid.org/0000-0002-4638-2265)
- Marina García‐Morín (ORCID: https://orcid.org/0000-0003-1405-2912)
- José Bernabéu‐Wittel (ORCID: https://orcid.org/0000-0002-3639-8482)
- José Manuel Marco-Sánchez
- Francisco Arias‐Lotto
- Carolina Prat‐Torres
- Alba González‐Gerrero
Institutions
- Hospital Sant Joan de Déu Barcelona (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Universitario Virgen del Rocío (ES)
Publication Details
- Journal
- Pediatric Dermatology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1111/pde.70084
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00